There are two well characterized cannabinoid receptors (CBRs), CB1-Rs and CB2-Rs, with other candidates, such as GPR55, PPARs and vanilloid TRPV1 (VR1) receptors, which are either activated by cannabinoids and/or endocannabinoids (eCBs). The neuronal and functional expression of CB2-Rs in the brain has been much less well characterized in comparison with the expression of the ubiquitous CB1-Rs. CB2-Rs were previously thought to be predominantly expressed in immune cells in the periphery and were traditionally referred to as peripheral CB2-Rs. We and others have now demonstrated the expression of CB2-Rs in neuronal, glial and endothelial cells in the brain, and this warrants a re-evaluation of the CNS effects of CB2-Rs. In the present review we summarize our current understanding of CNR2 genomic structure, its polymorphic nature, subtype specificity, from mice to human subjects, and its variants that confer vulnerabilities to neuropsychiatric disorders beyond neuro-immuno-cannabinoid activity.
AchurRNFreemanWMVranaKE (2010) Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol5: 83–91.
2.
AgrawalAHinrichsALDunnG. (2008) Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Drug Alcohol Depend93: 12–20.
3.
AhnKMcKinneyMKCravattBF (2008) Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev108: 1687–1707.
4.
AndreassonSAllebeckPEngstromARydbergU (1987) Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet2: 1483–1486.
5.
AshtonJCGlassM (2007) The cannabinoid CB2 receptor as a target for inflammation dependent neurodegeneration. Curr Neuropharmacol5: 73–80.
6.
AshtonJCFribergDDarlingtonCLSmithPF (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett396: 113–116.
7.
AtwoodBKMackieK (2010) CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol160: 467–479.
8.
BaekJ-HZhengYDarlingtonCL. (2008) Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei. Acta Otolaryngol128: 1–7.
9.
BangaloreSSPrasadKMMontroseDMGoradiaDDDiwadkarVAKeshavanMS (2008) Cannabis use and brain structural alterations in first episode schizophrenia – a region of interest, voxel based morphometric study. Schizophr Res99: 1–6.
10.
BasavarajappaBSHungundBL (2005) Role of the endocannabinoid system in the development of tolerance to alcohol. Alcohol Alcohol40: 15–24.
11.
BenitoCNunezETolonRM. (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains. J Neurosci23: 11136–11141.
12.
BenitoCKimWKChavarriaI. (2005) A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci25: 2530–2536.
13.
BenitoCTolonRMPazosMR. (2008) Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol153: 277–285.
14.
BergKMKuninsHVJacksonJL. (2008) Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med121: 406–418.
15.
Bermudez-SilvaFJSerranoADiaz-MolinaFJ (2006) Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Eur J Pharmacol531: 282–284.
16.
Bermudez-SilvaFJSanchez-VeraISuarezJ (2007) Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol565: 207–211.
17.
BoyleAPDavisSShulhaHP. (2008) High-resolution mapping and characterization of open chromatin across the genome. Cell132: 311–322.
18.
BraffDLGeyerMASwerdlowNR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berlin)156: 234–258.
BrownSMWager-MillerJMackieK (2002) Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim Biophys Acta1576: 255–264.
21.
BruscoATaglaiferroPASaezT. (2008a) Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann NY Acad Sci1139: 450–457.
22.
BruscoATagliaferroPSaezT. (2008b) Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse62: 944–949.
23.
BuckleyNEMcCoyKLMezeyE. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur J Pharmacol396: 141–149.
24.
CabralGAGriffin-ThomasL (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med11: e3.
25.
CabralGARabornESGriffinL. (2008) CB2 receptors in the brain: role in central immune function. Br J Pharmacol153: 240–251.
26.
Castro-FornielesJDiazRGotiJ. (2010) Prevalence and factors related to substance use among adolescents with eating disorders. Eur Addict Res16: 61–68.
27.
ChinCLTovcimakAEHradilVP. (2008) Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI. Br J Pharmacol153: 367–379.
28.
ChoHKimKMKimYK. (2009) Human proline-rich nuclear receptor coregulatory protein 2 mediates an interaction between mRNA surveillance machinery and decapping complex. Mol Cell33: 75–86.
29.
CichonSCraddockNDalyM. (2009) Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry166: 540–556.
30.
De FilippisDSteardoAD’AmicoA. (2009) Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection. Sci World J9: 229–235.
31.
De MarchiNDe PetrocellisLOrlandoPDanieleFFezzaFDi MarzoV (2003) Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis2: 5.
32.
DuanJSandersARGejmanPV (2010) Genome-wide approaches to schizophrenia. Brain Res Bull83: 93–102.
33.
EdenbergHJKollerDLXueiX. (2010) Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res34: 840–852.
34.
Ellert-MiklaszewskaAGrajkowskaWGabrusiewiczK. (2007) Distinctive pattern of cannabinoid type II (CB2) expression in adult and pediatric brain tumors. Brain Res1137: 161–169.
35.
Fernandez-RuizJRomeroJVelascoG. (2006) Cannabinoid CB2 receptor: a new target for controlling neural cell survival. Trends Pharmacol Sci28: 39–45.
36.
Fernandez-RuizJPazoMRGarcia-ArencibiaX. (2008) Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol286: S91–S96.
37.
GaliegueSMarySMarchandJ. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem232: 54–61.
38.
Garcia-GutierrezMSManzanaresJ (2010) Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. J Psychopharmacol00:1–00.
GolechSAMcCarronRMChenY. (2004) Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Mol Br Res132: 87–92.
42.
GongJ-POnaiviESIshiguroH. (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res1071: 10–23.
43.
GriffinGWrayEJTaoQ. (1999) Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for CB2 receptor absence in the rat central nervous system. Eur J Pharmacol377: 117–125.
44.
GrimseyNLGoodfellowCEScotterEL. (2008) Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal. J Neurosci Methods171: 78–86.
45.
HasinDSGoodwinRDStinsonFSGrantBF (2005) Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry62: 1097–1106.
46.
HillELGallopinTFerezouI. (2007) Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol97: 2580–2589.
47.
HoffmanHSIsonJR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev87: 175–189.
48.
HollidayEGNyholtDRTirupatiS. (2009) Strong evidence for a novel schizophrenia risk locus on chromosome 1p31.1 in homogeneous pedigrees from Tamil Nadu, India. Am J Psychiatry166: 206–215.
49.
HolmansPARileyBPulverAE. (2009) Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms. Mol Psychiatry14: 786–795.
50.
IbrahimMDengHZvonokK. (2003) Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the brain. Proc Natl Acad Sci100: 10529–10533.
51.
IshiguroHIwasakiSTeasenfitzL. (2007) Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J7: 380–385.
IshiguroHCarpioOHoriuchiY. (2010b) A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands. Synapse64: 92–96.
54.
Jean-GillesLGranBConstantinescuCS (2010) Interaction between cytokines, cannabinoids and the nervous system. Immunology215: 606–610.
55.
JhaveriMDElmesSJRichardsonD. (2008) Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. Eur J Neurosci27: 1722–1730.
56.
JoostenMValkPJVankanY. (2000) Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. Virology268: 308–318.
57.
KarsakMCohen-SolalMFreudenbergJ. (2005) Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum Mol Genet14: 3389–3396.
58.
KochMHabazettiIDehghaniF. (2008) The rat pineal gland comprises an endocannabinoid system. J Pineal Res45: 351–360.
59.
KoetheDLlenosICDulayJR. (2007) Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression. J Neural Transm114: 1055–1063.
60.
KousseffBGBeratisNGStraussL. (1976) Fucosidosis type 2. Pediatrics57: 205–213.
61.
LanciegoJLBarroso-ChineaPRicoAJ. (2010) Expression of mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis. J Psychopharmacol25: 97–104.
62.
LappalainenJKranzlerHRPetrakisI. (2004) Confirmation and fine mapping of the chromosome 1 alcohol dependence risk locus. Mol Psychiatry9: 312–319.
63.
LewekeFMGiuffridaAWursterUEmrichHMPiomelliD (1999) Elevated endogenous cannabinoids in schizophrenia. Neuroreport10: 1665–1669.
64.
LewekeFMGiuffridaAKoetheD. (2007) Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res94: 29–36.
65.
LiCYZhangYWangZ. (2010) A human-specific de novo protein-coding gene associated with human brain functions. PLoS Comput Biol6: e1000734.
66.
LindPAMacgregorSVinkJM. (2010) A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Twin Res Hum Genet13: 10–29.
67.
LiuQRPanCHHishimotoA. (2009) Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands. Genes Brain Behav8: 519–330.
68.
LongLEMaloneDTTaylorDA (2006) Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice. Neuropsychopharmacology31: 795–803.
69.
LopezEMTagliaferroPOnaiviESLopez-CostaJJ (2010) Distribution of CB2 cannabinoid receptor in adult retina. Synapse. Epub ahead of print.
70.
LunnCAReichE-PFineJS. (2008) Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists. Br J Pharmacol153: 226–239.
71.
MalikPGasserRWKemmlerG. (2009) Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res33: 375–381.
72.
MarriotKSHuffmanJW (2008) Recent advances in the development of selective ligands for cannabinoid CB(2) receptor. Curr Top Med Chem8: 187–204.
73.
McPartlandJMMatiasIDi MarzoV. (2006) Evolutionary origins of the endocannabinoid system. Gene370: 64–74.
74.
MorganCJCurranHV (2008) Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. Br J Psychiatry192: 306–307.
75.
MorganNHStanfordIMWoodhallGL (2009) Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology57: 356–368.
76.
MullerNSchwarzM (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res10: 131–148.
77.
MunroSThomasKLAbu-ShaarM (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature365: 61–65.
78.
MurikinatiSJuttlerEKeinertT. (2010) Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment. FASEB J24: 788–798.
79.
NagarkattiPPandeyRRiederSA. (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem1: 1333–1349.
80.
NunezEBenitoCPazosMR. (2004) Cannabinoid CB2 receptors are expressed by perivascular microglia cells in the human brain: an immunohistochemical study. Synapse53: 208–213.
81.
OnaiviES (2006) Neuropsychopharmacological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology54: 231–246.
82.
OnaiviES (2009) Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications. Int Rev Neurobiol88: 335–369.
83.
OnaiviES (2010) Endocannabinoid system, pharmacogenomics and response to therapy. Pharmacogenomics11: 907–910.
84.
OnaiviESIshiguroHGongJP. (2006a) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann NY Acad Sci1074: 514–536.
85.
OnaiviESIshiguroHPatelS (2006b) Methods to study the behavioral effects and expression of CB2 cannabinoid receptors and its gene transcripts in chronic mild stress model of depression. In: OnaiviES (ed.) Marijuana and Cannabinoid Research: Methods and Protocols. Totowa: Humana Press Inc, 291–298.
86.
OnaiviESIshiguroHGongJ-P. (2008a) Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann NY Acad Sci1130: 434–449.
87.
OnaiviESCarpioOIshiguroH. (2008b) Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Ann NY Acad Sci1139: 426–433.
88.
OngWYMackieK (1999) A light and electron microscopic study of the CB1 cannabinoid receptor in primate spinal cord. J Neurocytol28: 39–45.
89.
Ortega-AlvaroAAracil-FernandezAGarcia-GutierrezMS. (2010) Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Soc Neuro Abst471: 11.
PaldyEBereczkiESanthaM. (2008) CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB2 receptor in pain. Neurochem Int53: 309–316.
92.
PaldyovaEBereczkiESanthaM. (2008) Noladin ether, a putative endocannabinoid, inhibits mu-opoid receptor activation via CB2 cannabinoid receptors. Neurochem Int52: 321–328.
93.
PatelKDDavisonJSPittmanQJ. (2010) Cannabinoid CB2 receptors in health and disease. Curr Med Chem17: 1394–1410.
94.
PattersonPH (2009) Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res204: 313–321.
95.
PetersENHughesJR (2010) Daily marijuana users with past alcohol problems increase alcohol consumption during marijuana abstinence. Drug Alcohol Depend106: 111–118.
96.
PiontkivskaHYangMQLarkinDM. (2009) Cross-species mapping of bidirectional promoters enables prediction of unannotated 5’ UTRs and identification of species-specific transcripts. BMC Genomics10: 189.
97.
PlackettTPKovacsEJ (2008) Acute models of ethanol exposure to mice. Methods Mol Biol447: 3–9.
98.
RennJHYangNPChuehCMLinCYLanTHChouP (2009) Bone mass in schizophrenia and normal populations across different decades of life. BMC Musculoskelet Disord10: 1.
99.
RiversJRAshtonJC (2010) The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. Cent Nerv Syst Agents Med Chem10: 47–64.
Rodriguez-MartinIHerrero-TurrionMJMarron Fdez de VelascoEGonzalez-SarmientoRRodriguezRE (2007) Characterization of two duplicate zebrafish Cb2-like cannabinoid receptors. Gene389: 36–44.
102.
Ruiz-ValdepenasLBenitoCTolonRM. (2010) The endocannabinoid system and amyloid-related diseases. Exp Neurol224: 66–73.
103.
SammarcoCL (2007) A case study: identifying alcohol abuse in multiple sclerosis. J Neurosci Nurs39: 373–376.
104.
SampsonHW (2002) Alcohol and other factors affecting osteoporosis risk in women. Alcohol Res Health26: 292–298.
105.
SartorCEGrantJDBucholzKK. (2010) Common genetic contributions to alcohol and cannabis use and dependence symptomatology. Alcohol Clin Exp Res34: 545–554.
106.
ShengWSHuSMinX. (2005) Synthetic cannabinoid WIN55212-2 inhibits generation of inflammatory mediators by IL-IB-stimulated human astrocytes. Glia49: 211–219.
107.
SipeJCArbourNGerberABeutlerE (2005) Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J Leukoc Biol78: 231–238.
108.
SobieszczukDFPoliakovAXuQWilkinsonDG (2010) A feedback loop mediated by degradation of an inhibitor is required to initiate neuronal differentiation. Genes Dev242: 206–218.
109.
StrousRDShoenfeldY (2006) Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun27: 71–80.
110.
SuarezJBermudez-SilvaFJMackieK. (2008) Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. J Comp Neurol509: 400–421.
111.
SuarezJLlorenteRRomero-ZerboSY. (2009) Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats. Hippocampus19: 623–632.
112.
SwerdlowNRLightGACadenheadKSSprockJHsiehMHBraffDL (2006) Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry63: 1325–1335.
113.
TanasescuRConstantinescuCS (2010) Cannabinoids and the immune system: an overview. Immunology215: 588–597.
114.
TernianovAPerez-OrtizJMSolesioME. (2010) Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine. Neurobiol Aging00:1–00.
115.
TreutleinJCichonSRidingerM. (2009) Genome-wide association study of alcohol dependence. Arch Gen Psychiatry66: 773–784.
116.
UhlGRIshiguroHOnaiviES (2006) Molecular neurobiological methods in marijuana-cannabinoid research. In: OnaiviES (ed.) Marijuana and Cannabinoid Research: Methods and Protocols. Totowa: Humana Press Inc, 1–17.
117.
ValkPJHolSVankanY. (1997) The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11. J Virol71: 6796–6804.
118.
ValkPJVankanYJoostenM. (1999) Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2. J Virol73: 3595–3602.
119.
Van SickleMDDuncanMKingsleyPJ. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science310: 329–332.
120.
VinodKYHungundBL (2005) Endocannabinoid lipids and mediated system: implication for alcoholism and neuropsychiatric disorders. Life Sci77: 1569–1583.
121.
ViscomiMTOddiSLatiniL. (2009) Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the P13K/Akt pathway. J Neurosci29: 4564–4570.
122.
WardRJColivicchiMAAllenR. (2009) Neuro-inflammation induced in the hippocampus of ‘binge drinking’ rats may be mediated by elevated extracellular glutamate content. J Neurochem111: 1119–1128.
123.
XiZ-XSpillerKGardnerEL (2009) Cannabinoid CB1 and CB2 receptors modulate brainreward function in opposite directions in rats. Soc Neuro Abst449: 13.
124.
YamaguchiFMacraeADBrennerS (1996) Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubribes. Genomics35: 603–605.
125.
Yamaguchi-KabataYNakazonoKTakahashiA. (2008) Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet83: 445–456.
126.
ZammitSAllebeckPAndreassonSLundbergILewisG (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ325: 1199.
127.
ZhangJFeukLDugganGEKhajaRSchererSW (2006) Development of bioinformatics resources for display and analysis of copy number and other structural variants in the human genome. Cytogenet Genome Res115: 205–214.
128.
ZhouDShenRYeJJ. (2008) Nuclear receptor coactivator PNRC2 regulates energy expenditure and adiposity. J Biol Chem283: 541–553.
